Palvella Therapeutics (PVLA) Current Assets (2016 - 2023)
Historic Current Assets for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2023 value amounting to $7.5 million.
- Palvella Therapeutics' Current Assets fell 8972.0% to $7.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $7.5 million, marking a year-over-year decrease of 8972.0%. This contributed to the annual value of $7.5 million for FY2023, which is 8972.0% down from last year.
- Per Palvella Therapeutics' latest filing, its Current Assets stood at $7.5 million for Q4 2023, which was down 8972.0% from $59.1 million recorded in Q3 2023.
- Palvella Therapeutics' 5-year Current Assets high stood at $137.6 million for Q3 2021, and its period low was $7.5 million during Q4 2023.
- Over the past 5 years, Palvella Therapeutics' median Current Assets value was $91.5 million (recorded in 2020), while the average stood at $91.6 million.
- As far as peak fluctuations go, Palvella Therapeutics' Current Assets soared by 6854.64% in 2021, and later plummeted by 8972.0% in 2023.
- Over the past 5 years, Palvella Therapeutics' Current Assets (Quarter) stood at $115.0 million in 2019, then tumbled by 34.16% to $75.7 million in 2020, then skyrocketed by 68.55% to $127.6 million in 2021, then plummeted by 42.47% to $73.4 million in 2022, then crashed by 89.72% to $7.5 million in 2023.
- Its last three reported values are $7.5 million in Q4 2023, $59.1 million for Q3 2023, and $66.5 million during Q2 2023.